enX GROUP LIMITED - Trading Statement and Trading Update
What this filing means
enX Group anticipates total HEPS to fall 79% to 94% as its remaining core operations swing to a loss amid a 37% revenue contraction, though it has received R294.7 million from its Chemicals disposal.
enX is selling off large parts of its business and recently received R294.7 million for its Chemicals unit. However, the smaller business that remains is struggling with a 37% drop in sales and is currently losing money.
Bull case
- The successful closure of the Chemicals (WAG) transaction on 30 April 2026 has resulted in a significant cash inflow of R294.7 million, bolstering the balance sheet.
- The group has executed its strategic shift by restating and formally removing the Lubricants and Chemicals segments into discontinued operations.
- Total operations Basic EPS reflects a substantial mathematical improvement (up 98% to 111%), rebounding to a range of (1c) to 5c from a (44c) loss in the prior period.
Bear case
- Profitability in the remaining core business has collapsed, with continuing operations Basic and Headline EPS swinging to a loss of 2c to 4c per share from a 3c profit.
- Total HEPS is projected to plummet by 79% to 94% to a range of 3c to 10c, reflecting the structural loss of earnings from the divested segments.
- Continuing operations revenue is expected to drop by approximately 37%, dragged down by a lack of large data centre contracts and softer demand for generator sales.
- Net interest income has declined due to lower average cash balances following recent capital distributions to shareholders.
- A further R10 million impairment was recorded against the Chemical segment relative to its transaction value.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
enX Group's trading statement projects a 79% to 94% decline in total HEPS to 3c-10c, while confirming the receipt of R294.7 million from the finalized disposal of its Chemicals segment. The sharp earnings drop and a 37% revenue contraction in continuing operations highlight a difficult transition, as the leaner core business faces softer traditional demand and delays in lumpy project-based contracts. These are unaudited preliminary figures heavily distorted by IFRS 5 restructuring adjustments, not final audited results. Investor Takeaway: While the successful cash realization from asset disposals strengthens the balance sheet, the immediate equity thesis is weighed down by the swing to a loss in the remaining core operations. Signal-to-Price Note: The stock is flat on minimal volume despite the weak operational update, suggesting the market may have already priced in the restructuring transition.
Core operations show significant weakness following asset disposals. Await stabilization and a return to profitability in the remaining Power segment before committing fresh capital.
Decision framework
Current stance: Filing Negative
Key drivers
- The successful closure of the Chemicals (WAG) transaction on 30 April 2026 has resulted in a significant cash inflow of R294.7 million, bolstering the balance sheet.
- The group has executed its strategic shift by restating and formally removing the Lubricants and Chemicals segments into discontinued operations.
- Total operations Basic EPS reflects a substantial mathematical improvement (up 98% to 111%), rebounding to a range of (1c) to 5c from a (44c) loss in the prior period.
Key risks
- Profitability in the remaining core business has collapsed, with continuing operations Basic and Headline EPS swinging to a loss of 2c to 4c per share from a 3c profit.
- Total HEPS is projected to plummet by 79% to 94% to a range of 3c to 10c, reflecting the structural loss of earnings from the divested segments.
- Continuing operations revenue is expected to drop by approximately 37%, dragged down by a lack of large data centre contracts and softer demand for generator sales.
What would change the view
- Management provides credible upward guidance with measurable support.
- Margin/cash-flow quality improves in the next reporting cycle.
- Risk factors in this filing are explicitly resolved by subsequent disclosures.
Evidence from the filing
The successful closure of the Chemicals (WAG) transaction on 30 April 2026 has resulted in a significant cash inflow of R294.7 million, bolstering the balance sheet.
“Subsequent to period-end, all conditions precedent were fulfilled and the Transaction closed on 30 April 2026. Proceeds of R294.7 million were received”
The group has executed its strategic shift by restating and formally removing the Lubricants and Chemicals segments into discontinued operations.
“The Prior Period has been restated due to the classification of enX's Lubricant segment ("AG Lubricants") and enX's Chemical segment ("WAG") as disposal groups held for sale and discontinued operations”
Total operations Basic EPS reflects a substantial mathematical improvement (up 98% to 111%), rebounding to a range of (1c) to 5c from a (44c) loss in the prior period.
“Basic (loss) / earnings per share (1c) to 5c (44c) 98% to 111%”
Profitability in the remaining core business has collapsed, with continuing operations Basic and Headline EPS swinging to a loss of 2c to 4c per share from a 3c profit.
“Headline (loss) /earnings per share (2c) to (4c) 3c”
Total HEPS is projected to plummet by 79% to 94% to a range of 3c to 10c, reflecting the structural loss of earnings from the divested segments.
“HEPS 3c to 10c 47c (79%)to (94%)”
Continuing operations revenue is expected to drop by approximately 37%, dragged down by a lack of large data centre contracts and softer demand for generator sales.
“Revenue is expected to decrease by approximately 37%, primarily due to lower activity on large, project-based data centre contracts, which are inherently lumpy and dependent on project timing.”
Net interest income has declined due to lower average cash balances following recent capital distributions to shareholders.
“This is compounded by lower net interest income, reflecting reduced average cash balances following capital distributions to shareholders.”
A further R10 million impairment was recorded against the Chemical segment relative to its transaction value.
“and a further R10 million impairment was recorded relative to the Transaction value.”
More on enX Group Limited
Related filings
More from ENX
- enX GROUP LIMITED - Update to Salient Dates and Times
- enX GROUP LIMITED - Disposal of Securities by MCC Contracts Proprietary Limited (MCC Contracts)
- enX GROUP LIMITED - Results of General Meeting
- enX GROUP LIMITED - Distribution of Circular and Notice of General Meeting
- enX GROUP LIMITED - Firm Intention Announcement regarding the disposal by enX of the New Way Power Business and the enX Ventures Letting
Other Trading Statement
- PPRPUTPROP LIMITED - Further Trading Statement
- REMREMGRO LIMITED - Trading statement for the year ended 30 June 2026
- CPICAPITEC LIMITED - Trading Statement
- MSTMUSTEK LIMITED - Trading statement for the year ended 30 June 2026
- PANPAN AFRICAN RESOURCES FUNDING COMPANY LIMITED - Group Trading Statement for the year ended 30 June 2026